Use of Non-Steroidal Anti-Inflammatory Drugs and Associated Gastroprotection in a Cohort of Workers

María Jesús Lallana, Cristina Feja, Isabel Aguilar-Palacio, Sara Malo and María José Rabanaque
Additional contact information
María Jesús Lallana: Pharmacy Service in Primary Health Care, Aragones Health Service, 50009 Zaragoza, Spain
Cristina Feja: Deparment of Microbiology, Preventive Medicine and Public Health, University of Zaragoza, 50009 Zaragoza, Spain
Isabel Aguilar-Palacio: Deparment of Microbiology, Preventive Medicine and Public Health, University of Zaragoza, 50009 Zaragoza, Spain
Sara Malo: Deparment of Microbiology, Preventive Medicine and Public Health, University of Zaragoza, 50009 Zaragoza, Spain
María José Rabanaque: Deparment of Microbiology, Preventive Medicine and Public Health, University of Zaragoza, 50009 Zaragoza, Spain

IJERPH, 2018, vol. 15, issue 9, 1-9

Abstract: Background: This study describes the prevalence of non-steroidal anti-inflammatory drug (NSAID) use, and analyses prescribing patterns of NSAIDs and associated gastroprotection. Methods: The study population consisted of 5650 workers at the General Motors automobile assembly plant in Zaragoza, Spain. NSAID prescription data for 2014 were obtained from the prescription database of Aragon (Spain). NSAID consumption was determined based on the number of defined daily doses purchased per year. Heavy NSAIDs users were identified using Lorenz curves. Results: NSAID use in the cohort was high (40.7% of workers, 95% CI 39.4–41.9). The prescription of proton pump inhibitors increased with age. Gastrointestinal protection was lacking in some participants who were being treated with drugs associated with a high risk of gastrointestinal bleeding. Heavy NSAID users (defined as those above the 95th percentile of consumption), accounted for 26% of total DDDs, and consumed a greater proportion of coxibs than non-heavy users. Conclusions: The rate of NSAID consumption in the cohort was high. To reduce the risk of gastrointestinal complications, monitoring and adequate gastroprotection are essential in patients who are prescribed NSAIDs for long periods of time or who are treated concomitantly with drugs that increase the risk of gastrointestinal bleeding.

Keywords: non-steroidal anti-inflammatory drugs; gastrointestinal protection; pharmacoepidemiology (search for similar items in EconPapers)
JEL-codes: I I1 I3 Q Q5 (search for similar items in EconPapers)
Date: 2018
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://www.mdpi.com/1660-4601/15/9/1836/pdf (application/pdf)
https://www.mdpi.com/1660-4601/15/9/1836/ (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:gam:jijerp:v:15:y:2018:i:9:p:1836-:d:165697

Access Statistics for this article

IJERPH is currently edited by Ms. Jenna Liu

More articles in IJERPH from MDPI
Bibliographic data for series maintained by MDPI Indexing Manager ().